This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Non-Hodgkin lymphoma
  • /
  • Randomized phase II trial comparing obinutuzumab (...
Journal

Randomized phase II trial comparing obinutuzumab (GA101) with rituximab in patients with relapsed CD20+ indolent B-cell non-Hodgkin lymphoma: final analysis of the GAUSS study.

Read time: 1 mins
Published:20th Oct 2015
Author: Sehn LH, Goy A, Offner FC, Martinelli G, Caballero MD, Gadeberg O, et al.
Availability: Free full text
Ref.:J Clin Oncol. 2015;33:3467-74.
DOI:10.1200/JCO.2014.59.2139.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest